Bill to let state distribution programs offer GLP‑1 drugs moves forward
SB 1089, authorizing CalRx/HCAI to offer GLP‑1 medications through state distribution channels to expand affordable access, was advanced as amended; the author described personal benefits and asked for flexibility to include future products. Members raised questions about procurement, liability, age limits, and appropriation.
The full story
SB 1089 was presented to the Assembly Health Committee as a measure to expand affordable access to GLP‑1 medications through the state's CalRx and HCAI distribution mechanisms.
Sign up to keep reading.
Your free newsletter brings you what your city council, county, and school board discussed and decided.
or
Free account
Keep reading for free
Create a free account to finish this story and see the video, transcript and key details.
Continue with GoogleContinue with emailAlready have an account? Log in